Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Zvi Steinberg who wrote (769)	5/10/1999 9:36:00 PM
From: crysball	Respond to of 1386

Ariella, One Financial PR subject you or someone at PARS might want to address is the extremely outdated Management Discussion which appears in Zack's writeup of PARS..........especailly in view of the Q1 results. Arnie, The B&L relationship is like being chained to a large ( and organizationally very lethargic) turtle, it's progress is terribly slow (but it is progress). Frankly, I have to admire PARS management for holding the line when B&L tried to renegotiate the license terms. One subject I would like discussed at the conference call is the intermnably long timetable on TobraLE. Is B&L dragging their feet?